ICAM1 and coronary artery disorder: In CAD, principal mediators include pro-inflammatory cytokines (e.g., IL-6, TNF-α) (9), adhesion molecules (e.g., ICAM-1, VCAM-1) (10), and aberrant lipid metabolism (e.g., APOE, LDLR) (11).